Click on the links for the latest information on any of these trials OR new concepts in development.
Download the ALTG Research Report 2004 – 2016
Active Trials – Recruiting or in Study Start-Up
The following ALTG trials are recruiting or in the study start-up stage
Trials In Follow Up (closed to recruitment)
Currently there are no ALTG trials in the follow-up stage
|Trial Number||Title||Information Link|
Cobadged/ Endorsed Trials
The following trials have been endorsed by the ALTG
|Trial Number||Title||More Information|
|ALTG 04/001||Randomized comparison of first line docetaxel/gemcitabine doublet chemotherapy versus sequential single agent chemotherapy||Published
P-554 Randomized Phase II study of first-line docetaxel (D)/ gemcitabine (G) doublet chemotherapy versus fixed duration (3 cycles) sequential single agent chemotherapy (D then G) in Stage IIIB/IV non-small cell lung cancer (NSCLC)—Final Results. A study by the NSW and Australian Lung Cancer Trials Group
Pavlakis, N. et al.
Lung Cancer , Volume 49 , S263
|ALTG 04/003||MATES - Maintenance Thalidomide in Mesothelioma Patients||Published
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study
Buikhuisen, Wieneke A et al.
The Lancet Oncology , Volume 14 , Issue 6 , 543 - 551
|ALTG 04/009||PACT - Lung Cancer Patient Preferences||Moth et al. Lung Cancer 2016|
|ALTG 06/003||NITRO: A randomised, phase III trial of adding nitroglycernin to first line chemotherapy in advanced non-small cell lung cancer.||Davidson et al Ann Oncol 2015|
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
Laurie, S.A. et al.
European Journal of Cancer , Volume 50 , Issue 4 , 706 - 712
|ALTG 09/002||BR26||Ellis et al Lancet Oncol 2014|
|ALTG 09/004||B2P2M2||Nowak et al Lung Cancer 2013|
|ALTG 10/002||A Pilot Study To Develop A Classification Algorithm For Identifying Patients With Adenocarcinoma Of Lung Suitable For Individualized Therapies||Study completed late 2011|
|ALTG 10/003||Implementing standardised PET procedures for scanning, data collection and reporting in patients with NSCLC across Australia’s ALTG sites: A feasibility study.||Study completed late 2011|
|ALTG 10/004||Limiting the functional decline of patients with advanced non-small cell lung cancer.||Study completed|